TINAG Antikörper (Middle Region)
Kurzübersicht für TINAG Antikörper (Middle Region) (ABIN1109260)
Target
Alle TINAG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- VAADRIAIQS KGRYTANLSP QNLISCCAKN RHGCNSGSID RAWWYLRKRG
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Bovine.
Species reactivity (tested):Human. -
Aufreinigung
- Immunoaffinity column
-
Immunogen
- Synthetic peptide directed towards the middle region of human TINAG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8 °C for one month or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or (in aliquots) at -20 °C long term.
-
-
- TINAG (Tubulointerstitial Nephritis Antigen (TINAG))
-
Andere Bezeichnung
- TINAG
-
Hintergrund
- TINAG is a basement membrane glycoprotein initially identified as a target of antibodies in some forms of immunologically mediated tubulointerstitial nephritis.Synonyms: TIN-Ag, Tubulointerstitial nephritis antigen
-
Molekulargewicht
- TINAG: 54 kDa
-
Gen-ID
- 27283
-
NCBI Accession
- NM_014464
Target
-